Bioavailability of Combination Tablet BI 1356/Metformin Compared With Single BI 1356 and Metformin Administered Together to Healthy Male and Female Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The objective was to assess the relative bioavailability of a pilot scale linagliptin 2.5 mg / metformin 1000 mg fixed dose combination (FDC) tablet in comparison with single tablets of linagliptin 2.5 mg and metformin 1000 mg administered together.
Epistemonikos ID: ca840255addc39b8b9c1331fc98f41c0719cc03f
First added on: May 11, 2024